Pharmaceutical

Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval

Rusan Pharma's new facility in India will enhance its global capabilities and expand its API product portfolio.

Jul 22, 2024 - 04:00
Rusan Pharma’s API Plant in Ankleshwar Receives USFDA GMP Approval
Rusan Pharma's new facility in India will enhance its global capabilities and expand its API product portfolio.
Read the original article

Tags:

Previous Article

New genetic test will eliminate a form of inherited blindness in dogs

Next Article

Certara sees highest patent filings and grants during June in Q2 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Specialised Therapeutics licenses CanariaBio’s ovarian cancer antibody

Specialised Therapeutics licenses CanariaBio’s ovarian ...

Oct 13, 2023

Opinion: Hospital systems have to decide: Do they want to be Apple or Android?

Opinion: Hospital systems have to decide: Do they want ...

Nov 15, 2023

Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government

Stéphane Bancel, Bernie Sanders spar over what Moderna ...

Mar 22, 2023